|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Ariad_Pharmaceuticals
|
|
gptkbp:acquisition
|
none reported
|
|
gptkbp:business_model
|
biopharmaceutical development
|
|
gptkbp:can_lead_to
|
gptkb:Selinexor
|
|
gptkbp:ceo
|
gptkb:Michael_Kauffman
|
|
gptkbp:clinical_trial
|
gptkb:healthcare_organization
ongoing
multiple phases
ongoing studies
in development
Phase 1, Phase 2, Phase 3
various phases
published in journals
diverse drug candidates
for Selinexor
|
|
gptkbp:collaborations
|
academic institutions
with research institutions
|
|
gptkbp:community_engagement
|
active in patient advocacy
|
|
gptkbp:employees
|
approximately 200
|
|
gptkbp:financial_performance
|
published yearly
|
|
gptkbp:financial_products
|
publicly traded
|
|
gptkbp:focus
|
cancer therapeutics
|
|
gptkbp:founded
|
gptkb:2010
|
|
gptkbp:founder
|
gptkb:Michael_Kauffman
|
|
gptkbp:grants
|
received from government
|
|
gptkbp:headquarters
|
gptkb:Newton,_Massachusetts
|
|
gptkbp:healthcare
|
FDA approved drugs
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Karyopharm Therapeutics Inc.
|
|
gptkbp:invention
|
held in various areas
|
|
gptkbp:investment
|
available online
various venture capital firms
regularly provided
oncology market
|
|
gptkbp:language_of_instruction
|
multiple drug candidates
|
|
gptkbp:market_cap
|
varies
|
|
gptkbp:marketing_strategy
|
focus on innovation
|
|
gptkbp:partnership
|
biotech firms
|
|
gptkbp:partnerships
|
various pharmaceutical companies
|
|
gptkbp:products
|
gptkb:Selinexor
|
|
gptkbp:publishes
|
numerous
|
|
gptkbp:receives_funding_from
|
secured from investors
|
|
gptkbp:regulatory_compliance
|
FDA approval for Selinexor
|
|
gptkbp:research
|
not publicly disclosed
focused on cancer
|
|
gptkbp:research_areas
|
oncology
|
|
gptkbp:research_focus
|
nuclear transport
hematological malignancies
|
|
gptkbp:scholarships
|
from investors
|
|
gptkbp:staff
|
renowned scientists
|
|
gptkbp:strategic_importance
|
expand drug pipeline
|
|
gptkbp:symbol
|
KPTI
|
|
gptkbp:team
|
experienced professionals
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.karyopharm.com
|